Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Kensey Nash pays $20mm cash for Nerites

Executive Summary

Kensey Nash Corp. (specializes in resorbable biomaterials) has acquired essentially all of the net assets and operational liabilities of Nerites Corp., a private company focused on surgical adhesives for natural tissue repair. Kensey will pay $17mm cash up front and is holding another $3mm as security for potential indemnification obligations. As long as they haven’t been applied to such obligations, the funds will be released in two equal increments at both the one- and two-year anniversaries of the deal’s closing.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
      • Surgical Sealants
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Full Acquisition
    • Includes Contract
    • Intra-Biotech Deal
    • Payment Includes Cash

Related Companies